Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020
   PCE(x) 22.5240.6336.99-

What is the latest Price to Cash Earnings (PCE) ratio of GLAND PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of GLAND PHARMA is 22.52 based on Mar2023 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202322.52
Mar202240.63
Mar202136.99
Mar2020-

How is Price to Cash Earnings (PCE) of GLAND PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2023 22.52
-44.57
Mar2022 40.63
9.84
Mar2021 36.99
0
Mar2020 0 -

Other Financial Ratios of GLAND PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,732.2 Cr -2.6% -7.3% 26.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.6%

-7.3%

26.7%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses